On the Mad in America podcast this wweek we are joined by renowned psychopharmacologist Dr David Healy. David is a psychiatrist, scientist and author. Before becoming a professor of Psychiatry in Wales, and more recently in the Department of Family Medicine at McMaster University in Canada, he studied medicine in Dublin and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology, and has authored more than 220 peer-reviewed articles, 300 other pieces, and 25 books, including The Antidepressant Era, The Creation of Psychopharmacology and Pharmageddon. He has been involved as an expert witness in homicide and suicide trials involving psychotropic drugs, and in bringing problems with these drugs to the attention of American and European regulators, as well raising awareness of how pharmaceutical companies sell drugs by marketing diseases and co-opting academic opinion-leaders, ghost-writing their articles. David is a founder and CEO of Data Based Medicine Limited, which operates through its website RxISK.org, dedicated to making medicines safer through online direct patient reporting of drug side effects. In this interview we discuss the recently held World Tapering Day, a possible relationship between antidepressant treatment and sensory neuropathy and the difficulties that can be encountered when trying to deprescribe.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.